News
With the Embabel agent framework, written in Kotlin, Rod Johnson aims not only to catch up with Python agent frameworks, but ...
Sarepta Therapeutics has followed through on its promise to file for accelerated approval of its gene therapy SRP-9001 for Duchenne muscular dystrophy (DMD), as it aims for a launch in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results